IRIS
SCARFO', LYDIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 671
NA - Nord America 536
AS - Asia 484
OC - Oceania 10
AF - Africa 3
Totale 1.704
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 525
SE - Svezia 323
CN - Cina 299
SG - Singapore 162
IT - Italia 121
RU - Federazione Russa 102
FI - Finlandia 21
IE - Irlanda 18
DE - Germania 17
GR - Grecia 14
NL - Olanda 13
BE - Belgio 11
AU - Australia 10
CA - Canada 8
FR - Francia 8
IN - India 7
AE - Emirati Arabi Uniti 6
GB - Regno Unito 6
PL - Polonia 4
NO - Norvegia 3
PA - Panama 3
CZ - Repubblica Ceca 2
DK - Danimarca 2
ES - Italia 2
IL - Israele 2
IR - Iran 2
PK - Pakistan 2
AT - Austria 1
ET - Etiopia 1
HK - Hong Kong 1
HU - Ungheria 1
KR - Corea 1
KZ - Kazakistan 1
LT - Lituania 1
MA - Marocco 1
NA - Namibia 1
PH - Filippine 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 1.704
Salva come PNG Salva come JPEG
Città #
Shanghai 181
Singapore 109
Ashburn 107
Lawrence 97
Princeton 97
Moscow 56
New York 56
Milan 45
Boardman 29
Dublin 18
Guangzhou 14
Helsinki 13
Thessaloniki 12
Rome 8
Beijing 7
Buffalo 7
Shenzhen 7
Wuxi 7
Dallas 6
Dubai 6
Mol 6
Brussels 5
Los Angeles 5
Sydney 5
Ferrara 4
Hangzhou 4
Lappeenranta 4
Meppel 4
Pune 4
Seattle 4
Warsaw 4
Amsterdam 3
Jiaxing 3
Montreal 3
Naples 3
Panama City 3
Portland 3
Toronto 3
Zhengzhou 3
Ancona 2
Athens 2
Barcelona 2
Bergen 2
Birmingham 2
Columbus 2
Frankfurt am Main 2
Genoa 2
Gorle 2
Gujranwala 2
Melbourne 2
Mountain View 2
Nanjing 2
Padova 2
Paris 2
Prague 2
San Maurizio d'Opaglio 2
Strasbourg 2
Treviolo 2
Valenzano 2
Vellore 2
Addis Ababa 1
Alessandria 1
Almaty 1
Anzio 1
Baoding 1
Bolton 1
Bratislava 1
Burbach 1
Cheshire 1
Dalian 1
Delhi 1
Easley 1
Esslingen am Neckar 1
Fes 1
Foshan 1
Fremont 1
Gioia Tauro 1
Groningen 1
Handan 1
Islington 1
Ismaning 1
Lomazzo 1
Lonate Pozzolo 1
London 1
Macerata 1
Munich 1
Nauka 1
Newark 1
Novara 1
Oslo 1
Ottawa 1
Quezon City 1
Redmond 1
Redwood City 1
Rockville 1
Sarcedo 1
Sassuolo 1
Seodaemun-gu 1
Seregno 1
Sopron 1
Totale 1.037
Salva come PNG Salva come JPEG
Nome #
Exploring Perceptions, Opinions, and Needs of Adult and Pediatric Cancer Patients, Caregivers, and Healthcare Professionals Towards Low-Fidelity Versions of the MyPal Project's Applications: Findings from 12 Pre-Pilot Focus Groups in 4 European Countries of an ePRO Intervention for Palliative Cancer Care (Preprint) 45
Lenalidomide enhances CD23.CAR T cell therapy in chronic lymphocytic leukemia 28
Targeting the LYN/HS1 signaling axis in chronic lymphocytic leukemia 26
3D co-culture model of chronic lymphocytic leukemia bone marrow microenvironment predicts patient-specific response to mobilizing agents 25
A retinoic acid-dependent stroma-leukemia crosstalk promotes chronic lymphocytic leukemia progression 24
IκBε deficiency accelerates disease development in chronic lymphocytic leukemia 23
3D Bioprinting Allows the Establishment of Long-Term 3D Culture Model for Chronic Lymphocytic Leukemia Cells 23
Are we finally getting personal? Moving towards a personalized approach in chronic lymphocytic leukemia 23
BTK and PLCG2 remain unmutated in one-third of patients with CLL relapsing on ibrutinib 22
Inhibition of chronic lymphocytic leukemia progression by full-length chromogranin A and its N-terminal fragment in mouse models 22
A novel Rag2(-/-)gamma(-/-)(c)-xenograft model of human CLL 21
Bone Marrow Histopathology in the Diagnostic Evaluation of Splenic Marginal-zone and Splenic Diffuse Red Pulp Small B-cell Lymphoma: A Reliable Substitute for Spleen Histopathology? 21
COVID-19 and Chronic Lymphocytic Leukemia: Where We Stand Now 20
HIF-1α regulates the interaction of chronic lymphocytic leukemia cells with the tumor microenvironment 20
A novel ex vivo high-throughput assay reveals antiproliferative effects of idelalisib and ibrutinib in chronic lymphocytic leukemia 20
EZN-2208 treatment suppresses chronic lymphocytic leukaemia by interfering with environmental protection and increases response to fludarabine 20
Chronic lymphocytic leukemia management in Italy during the COVID-19 pandemic: A Campus CLL report 20
COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study 20
Assessing Patients' Knowledge on Chronic Lymphocytic Leukemia: Validation of the ERIC CLL Knowledge Questionnaire in Greece 20
Prognostic relevance of MYD88 mutations in CLL: the jury is still out 19
Calreticulin as a novel B-cell receptor antigen in chronic lymphocytic leukemia 19
The inhibitory receptor toll interleukin-1R 8 (TIR8/IL-1R8/SIGIRR) is downregulated in chronic lymphocytic leukemia 19
Olaptesed pegol (NOX-A12) with bendamustine and rituximab: a phase IIa study in patients with relapsed/refractory chronic lymphocytic leukemia 19
T-Cell Dynamics in Chronic Lymphocytic Leukemia under Different Treatment Modalities 19
Invariant NKT cells contribute to chronic lymphocytic leukemia surveillance and prognosis 19
3D-STED Super-Resolution Microscopy Reveals Distinct Nanoscale Organization of the Hematopoietic Cell-Specific Lyn Substrate-1 (HS1) in Normal and Leukemic B Cells 19
PYK2 is overexpressed in chronic lymphocytic leukaemia: A potential new therapeutic target 18
In Vitro Sensitivity of CLL Cells to Fludarabine May Be Modulated by the Stimulation of Toll-like Receptors 18
BTK Inhibition Impairs the Innate Response Against Fungal Infection in Patients With Chronic Lymphocytic Leukemia 18
Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL 18
Spontaneous regression in chronic lymphocytic leukaemia. Clinical features of 50 cases from the ERIC registry and review of the literature 17
Anti-CD20 rechallenge with ofatumumab in relapsed/refractory splenic marginal zone lymphoma: the MORE trial 17
MINIMAL RESIDUAL DISEASE-DRIVEN TREATMENT INTENSIFICATION WITH SEQUENTIAL ADDITION OF IBRUTINIB TO VENETOCLAX IN R/R CLL 17
Clinical effect of stereotyped B-cell receptor immunoglobulins in chronic lymphocytic leukaemia: a retrospective multicentre study 17
Targeting B-cell anergy in chronic lymphocytic leukemia. 17
General population low-count CLL-like MBL persists over time without clinical progression, although carrying the same cytogenetic abnormalities of CLL. 17
Chemo-immunotherapy for Older Patients with Chronic Lymphocytic Leukemia - Time to Retire? 17
Acalabrutinib: a highly selective, potent Bruton tyrosine kinase inhibitor for the treatment of chronic lymphocytic leukemia 17
A single-tube multiplex method for monitoring mutations in cysteine 481 of Bruton Tyrosine Kinase (BTK) gene in chronic lymphocytic leukemia patients treated with ibrutinib 17
MyPal-Child study protocol: An observational prospective clinical feasibility study of the MyPal ePRO-based early palliative care digital system in paediatric oncology patients 17
MicroRNA and proliferation control in chronic lymphocytic leukemia: functional relationship between miR-221/222 cluster and p27 16
Reply to "CLL and COVID-19 at the Hospital Clinic of Barcelona: an interim report" Analysis of six hematological centers in Lombardy : On behalf of CLL commission of Lombardy Hematology Network (REL) 16
Outcomes of patients with hematologic malignancies and COVID-19: A systematic review and meta-analysis of 3377 patients 16
Relevance of Minimal Residual Disease in the Era of Targeted Agents 16
Establishment and Characterization of PCL12, a Novel CD5+ Chronic Lymphocytic Leukaemia Cell Line 16
Profiling the Genomic Landscape at the Early Stages of CLL: Low Genomic Complexity and Paucity of Driver Mutations in MBL and Indolent CLL 16
Management of chronic lymphocytic leukemia in Italy during a one year of the COVID-19 pandemic and at the start of the vaccination program. A Campus CLL report 16
Dimethyl itaconate selectively targets inflammatory and metabolic pathways in chronic lymphocytic leukemia 15
CLL-like monoclonal B-cell lymphocytosis: are we all bound to have it? 15
Monoclonal B lymphocytosis in the general population 15
Monoclonal B cell lymphocytosis and "in situ" lymphoma 15
MBL Versus CLL How Important Is the Distinction? 15
Reprogramming cell death: BCL2 family inhibition in hematological malignancies 15
Distinct patterns of novel gene mutations in poor-prognostic stereotyped subsets of chronic lymphocytic leukemia: the case of SF3B1 and subset #2 15
Chronic lymphocytic leukaemia 15
Chronic Lymphocytic Leukemia with Mutated IGHV4-34 Receptors: Shared and Distinct Immunogenetic Features and Clinical Outcomes 15
Interleukin-1 receptor-associated kinase 4 inhibitor interrupts toll-like receptor signalling and sensitizes chronic lymphocytic leukaemia cells to apoptosis 15
Frontline treatment with the combination obinutuzumab ± chlorambucil for chronic lymphocytic leukemia outside clinical trials: Results of a multinational, multicenter study by ERIC and the Israeli CLL study group 15
A First-in-human Study of Tenalisib (RP6530), a Dual PI3K δ/γ Inhibitor, in Patients With Relapsed/Refractory Hematologic Malignancies: Results From the European Study 15
Trabectedin reveals a strategy of immunomodulation in chronic lymphocytic leukemia 15
High-throughput analysis of the T-cell receptor gene repertoire in low-count monoclonal B-cell lymphocytosis reveals a distinct profile from chronic lymphocytic leukemia 15
T cell receptor gene repertoire profiles in subgroups of patients with chronic lymphocytic leukemia bearing distinct genomic aberrations 14
CLL-461 Humoral Response to COVID-19 Vaccine: A Challenge in CLL 14
Impact of B-cell count and imaging screening in cMBL: any need to revise the current guidelines? 14
IgG-Switched CLL Has a Distinct Immunogenetic Signature from the Common MD Variant: Ontogenetic Implications 14
Immunogenetics shows that not all MBL are equal: the larger the clone, the more similar to CLL 14
The functional in vitro response to CD40 ligation reflects a different clinical outcome in patients with chronic lymphocytic leukemia. 14
No improvement in long-term survival over time for chronic lymphocytic leukemia patients in stereotyped subsets #1 and #2 treated with chemo(immuno)therapy 14
Tailored approaches grounded on immunogenetic features for refined prognostication in chronic lymphocytic leukemia 14
Infrequent "chronic lymphocytic leukemia-specific" immunoglobulin stereotypes in aged individuals with or without low count monoclonal B cell lymphocytosis 14
Dichotomous Toll-like receptor responses in chronic lymphocytic leukemia patients under ibrutinib treatment 14
The evolving treatment landscape of chronic lymphocytic leukemia 14
Toll-Like receptor stimulation in splenic marginal zone lymphoma can modulate cell signaling, activation and proliferation 14
Correction: Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY 13
The evolving landscape of COVID-19 and post-COVID condition in patients with chronic lymphocytic leukemia: A study by ERIC, the European research initiative on CLL 13
Thrombotic and bleeding complications in patients with chronic lymphocytic leukemia and severe COVID-19: a study of ERIC, the European Research Initiative on CLL 13
Targeting macrophages sensitizes chronic lymphocytic leukemia to apoptosis and inhibits disease progression 13
Not all IGHV3-21 chronic lymphocytic leukemias are equal: prognostic considerations 13
What does it mean i have a monoclonal B-cell lymphocytosis?: Recent insights and new challenges 13
Distinct homotypic B-cell receptor interactions shape the outcome of chronic lymphocytic leukaemia 13
Synthetic high-density lipoproteins as targeted monotherapy for chronic lymphocytic leukemia 13
Recurrent mutations refine prognosis in chronic lymphocytic leukemia 13
Exploiting B Cell Receptor Stereotypy to design Tailored Immunotherapy in Chronic Lymphocytic Leukemia 13
Response assessment to venetoclax in relapsed/refractory chronic lymphocytic leukemia by ultrasonography 13
Genetic and Phenotypic Attributes of Splenic Marginal Zone Lymphoma 13
MyPal ADULT study protocol: A randomised clinical trial of the MyPal ePRO-based early palliative care system in adult patients with haematological malignancies 13
Ibrutinib dose intensity in high-risk chronic lymphocytic leukemia 12
Different spectra of recurrent gene mutations in subsets of chronic lymphocytic leukemia harboring stereotyped B-cell receptors 12
Refractory and 17p-deleted chronic lymphocytic leukemia: improving survival with pathway inhibitors and allogeneic stem cell transplantation 12
EHA evaluation of the ESMO-Magnitude of Clinical Benefit Scale version 1.1 (ESMO-MCBS v1.1) for haematological malignancies 12
COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus 12
Single cell analysis reveals immune dysfunction from the earliest stages of CLL that can be reversed by ibrutinib 12
Monoclonal B Cell Lymphocytosis in Hepatitis C Virus Infected Individuals 11
High-dose clarithromycin is an active monotherapy for patients with relapsed/refractory extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT): The HD-K phase II trial 11
Clonal haematopoiesis as a risk factor for therapy-related myeloid neoplasms in patients with chronic lymphocytic leukaemia treated with chemo-(immuno)therapy 11
Preexisting and treatment-emergent autoimmune cytopenias in patients with CLL treated with targeted drugs 11
Continuous treatment with Ibrutinib in 100 untreated patients with TP53 disrupted chronic lymphocytic leukemia: A real-life campus CLL study 11
Clinical features, management, and prognosis of an international series of 161 patients with limited-stage diffuse large B-cell lymphoma of the bone (the IELSG-14 study) 10
Atezolizumab, venetoclax, and obinutuzumab combination in Richter transformation diffuse large B-cell lymphoma (MOLTO): a multicentre, single-arm, phase 2 trial 10
Disrupting pro-survival and inflammatory pathways with dimethyl fumarate sensitizes chronic lymphocytic leukemia to cell death 10
Totale 1.634
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.211
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.211
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202140 0 0 0 0 31 5 4 0 0 0 0 0
2021/202275 0 0 0 21 6 3 8 19 7 6 2 3
2022/2023616 215 113 54 1 16 82 23 34 40 8 11 19
2023/2024477 13 20 27 119 22 71 4 27 1 12 44 117
2024/2025664 276 53 63 60 87 125 0 0 0 0 0 0
Totale 1.926